Form D Explorer

Inspect source fieldsReport a record issue

Form D — Thiogenesis Therapeutics, Corp.

0001062993-25-013902 · filed Aug 8, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Other filings

Offering

Industry
Other
Exemptions
Rule 506(b)
Reported offering amount
$125,450
Reported amount sold
$125,450
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Thiogenesis Therapeutics, Corp.
CIK
1877778
Entity
Corporation
Jurisdiction
ONTARIO, CANADA
Year incorporated
—
Address
4 KING STREET WEST, SUITE 401
TORONTO, Ontario, Canada M5H 1B6
Phone
(888) 223-9165

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗